Back to search
FDAFDA · Food and drugs·Recall number D-0425-2025

KOFAL Original, Penetrating Pain Relieving Ointment (methyl salicylate 12% - Topical Analgesic), 4 oz (113 g) Jar, Distributed by: Pharmadel LLC, Georgetown, DE 199747, NDC 55758-106-04, UPC 8 9971100128 0.

Published May 28, 2025 · Recall initiated: April 24, 2025

Summary

FDA records drug Class II recall D-0425-2025, published May 28, 2025 and initiated April 24, 2025. Recalling firm: KENIL HEALTHCARE PRIVATE LIMITED; Status: Terminated; Reported quantity: 16,248 Jars; Lot: Lost SP21A, Exp Date: 03/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
KENIL HEALTHCARE PRIVATE LIMITED
Distributor
DE and NC
Lot
Lost SP21A, Exp Date: 03/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was KOFAL Original, Penetrating Pain Relieving Ointment (methyl salicylate 12% - Topical Analgesic), 4 oz (113 g) Jar, Distributed by: Pharmadel LLC, Georgetown, DE 199747, NDC 55758-106-04, UPC 8 9971100128 0. recalled?

Yes. FDA published recall D-0425-2025 on May 28, 2025. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit